The acquired division develops and produces innovative active ingredients, in addition to distributing active ingredients and special chemicals on behalf of third parties. In 2007, it posted revenues of US$222m of which 55% came from Europe (via Unipex, Chimiray, Siricie Iris and IEB) and 45% from North America (largely Canada via Multichem). The’ division has 155 employees and locations in Paris, Quebec and Toronto. Following the deal, its head quarters will remain in Quebec.